Council on Valvular Heart Disease Recommended Sessions at ESC Congress

ESC Congress 2026 in Munich

Discover the selection of sessions organised during the ESC Congress 2026 in Munich, recommended by the Council on Cardiovascular Heart Disease.

Sessions on Valvular heart Disease at ESC Congress

Frontiers in transcatheter mitral valve interventions

Congress Session

28 Aug 2026

Tricuspid regurgitation: medical treatment, intervention, or surgery?

Congress Session

28 Aug 2026

Progress in structural heart valve interventions: current status and perspectives - discussion

Congress Presentation

28 Aug 2026

Management of aortic valve disease: from guidelines to cases - get ready for the session

Congress Presentation

28 Aug 2026

Great Debate: transcatheter or surgical repair for degenerative mitral regurgitation?

Congress Session

29 Aug 2026

Great Debate: transcatheter mitral valve repair/replacement for secondary mitral regurgitation – routine or niche?

Congress Session

27 Aug 2021

Heart Team Discussion: optimal management of asymptomatic severe aortic stenosis

Congress Session

29 Aug 2026

Guidelines in Practice: aortic stenosis with significant coronary artery disease

Congress Session

30 Aug 2026

Paradoxical low-flow, low-gradient aortic stenosis: challenges, strategies, and implications

Congress Session

30 Aug 2026

Clinical Case Management: tricuspid regurgitation in patients with transvalvular leads

Congress Session

30 Aug 2026

Management of mitral regurgitation in complex scenarios

Congress Session

30 Aug 2026

Special focus on elderly patients with heart disease: what do we need to know when treating octogenarians?

Congress Session

30 Aug 2026

Predicting outcomes in tricuspid regurgitation

Congress Session

31 Aug 2026

How to use artificial intelligence in assessment of valve disease?

Congress Session

31 Aug 2026

Timing of intervention in aortic valve disease: is imaging all you need?

Congress Session

31 Aug 2026

Right ventricular function: getting it right?

Congress Session

31 Aug 2026

Council on Valvular Heart Disease Recommended Sessions at ESC Congress

ESC Congress 2026 in Munich

Sessions on Valvular heart Disease at ESC Congress

Frontiers in transcatheter mitral valve interventions

Tricuspid regurgitation: medical treatment, intervention, or surgery?

Progress in structural heart valve interventions: current status and perspectives - discussion

Management of aortic valve disease: from guidelines to cases - get ready for the session

Great Debate: transcatheter or surgical repair for degenerative mitral regurgitation?

Great Debate: transcatheter mitral valve repair/replacement for secondary mitral regurgitation – routine or niche?

Heart Team Discussion: optimal management of asymptomatic severe aortic stenosis

Guidelines in Practice: aortic stenosis with significant coronary artery disease

Paradoxical low-flow, low-gradient aortic stenosis: challenges, strategies, and implications

Clinical Case Management: tricuspid regurgitation in patients with transvalvular leads

Management of mitral regurgitation in complex scenarios

Special focus on elderly patients with heart disease: what do we need to know when treating octogenarians?

Predicting outcomes in tricuspid regurgitation

How to use artificial intelligence in assessment of valve disease?

Timing of intervention in aortic valve disease: is imaging all you need?

Right ventricular function: getting it right?

ESC Congress

Munich & Online, 28-31 August 2026